SCHEMBL284740

SCHEMBL284740

C=CC[Zr](Cl)(Cl)(Cl)C1C=Cc2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL437346 0.79 HTR6 (0.33) HTR6HTR2A
SCHEMBL5705660 0.78 HTR6 (0.32) HTR6HTR2A
SCHEMBL28978370 0.78 HTR6 (0.33) HTR6HTR2A
SCHEMBL437345 0.77 HTR6 (0.31) HTR6HTR2A
Hydrochloric Acid SCHEMBL441383 0.77 HTR6 (0.31) HTR6HTR2A
SCHEMBL218232 0.75 HTR2A (0.35) HTR6HTR2A
SCHEMBL441382 0.75 HTR6 (0.30) HTR6
SCHEMBL438073 0.74 HTR6 (0.30) HTR6HTR2A
SCHEMBL6725601 0.74 HTR6 (0.32) HTR6
SCHEMBL445165 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367853-B2 Method and system for forming a precursor compound for non-bridged unsymmetric polyolefin polymerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-02-05 US disclosed
EP-2427505-A1 METHOD AND SYSTEM FOR FORMING A PRECURSOR COMPOUND FOR NON-BRIDGED UNSYMMETRIC POLYOLEFIN POLYMERIZATION CATALYST Chevron Phillips Chemical Company LP (US) 2012-03-14 EP disclosed
WO-2011142735-A1 METHOD AND SYSTEM FOR FORMING A PRECURSOR COMPOUND FOR NON-BRIDGED UNSYMMETRIC POLYOLEFIN POLYMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-11-17 WO disclosed
US-20110275848-A1 METHOD AND SYSTEM FOR FORMING A PRECURSOR COMPOUND FOR NON-BRIDGED UNSYMMETRIC POLYOLEFIN POLYMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-11-10 US disclosed
US-8013177-B2 Method and system for forming a precursor compound for non-bridged unsymmetric polyolefin polymerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-09-06 US disclosed
US-20100292425-A1 METHOD AND SYSTEM FOR FORMING A PRECURSOR COMPOUND FOR NON-BRIDGED UNSYMMETRIC POLYOLEFIN POLYMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292425-A1 METHOD AND SYSTEM FOR FORMING A PRECURSOR COMPOUND FOR NON-BRIDGED UNSYMMETRIC POLYOLEFIN POLYMERIZATION CATALYST DHPS, PCBP1, GGPS1 HTR6 3576/4885HTR2A 3830/4885
US-20110275848-A1 METHOD AND SYSTEM FOR FORMING A PRECURSOR COMPOUND FOR NON-BRIDGED UNSYMMETRIC POLYOLEFIN POLYMERIZATION CATALYST DHPS, PCBP1, GGPS1 HTR6 3576/4885HTR2A 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.